Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Gammagard

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



Enid and George - Life with dementia

progressive dementia3 - calmeil1 - age-related cognitive disorders1 - caregiving2 - people with dementia4 - disorientation3 - national alzheimer's project act1 - chronic traumatic encephalopathy1 - movement disorder2 - apolipoprotein e41 - csf1 - loss of memory3 - early stage alzheimers1 - mayo clinic1 - amyloid beta 42 peptide1 - tomosyn1 - neocortex1 - brain tissue biopsy1 - sleep apnea1 - alzheimer's experience1 - invisible disease1 - alzheimer's research5 - parkinsons related dementia1 - lethal condition1 - medium spiny neurons1 - aphasia4 - symptoms of alzheimer's2 - vascular dementia13 - apoe gene3 - melancholia2 -